ID   NTRK3_HUMAN             Reviewed;         839 AA.
AC   Q16288; O75682; Q12827; Q16289;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   05-OCT-2010, entry version 126.
DE   RecName: Full=NT-3 growth factor receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=GP145-TrkC;
DE            Short=Trk-C;
DE   AltName: Full=Neurotrophic tyrosine kinase receptor type 3;
DE   AltName: Full=TrkC tyrosine kinase;
DE   Flags: Precursor;
GN   Name=NTRK3; Synonyms=TRKC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C).
RC   TISSUE=Fetal brain;
RX   MEDLINE=95104834; PubMed=7806211; DOI=10.1006/geno.1994.1383;
RA   McGregor L.M., Baylin S.B., Griffin C.A., Hawkins A.L., Nelkin B.D.;
RT   "Molecular cloning of the cDNA for human TrkC (NTRK3), chromosomal
RT   assignment, and evidence for a splice variant.";
RL   Genomics 22:267-272(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B; C AND D), AND PARTIAL
RP   PROTEIN SEQUENCE.
RC   TISSUE=Brain;
RX   MEDLINE=95123473; PubMed=7823156;
RA   Shelton D.L., Sutherland J., Gripp J., Camerato T., Armanini M.P.,
RA   Phillips H.S., Carroll K., Spencer S.D., Levinson A.D.;
RT   "Human trks: molecular cloning, tissue distribution, and expression of
RT   extracellular domain immunoadhesins.";
RL   J. Neurosci. 15:477-491(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=98449483; PubMed=9778053; DOI=10.1038/sj.onc.1202100;
RA   Ichaso N., Rodriguez R.E., Martin-Zanca D., Gonzalez-Sarmiento R.;
RT   "Genomic characterization of the human trkC gene.";
RL   Oncogene 17:1871-1875(1998).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 297-401, AND DISULFIDE BOND.
RX   PubMed=10388563; DOI=10.1006/jmbi.1999.2816;
RA   Ultsch M.H., Wiesmann C., Simmons L.C., Henrich J., Yang M.,
RA   Reilly D., Bass S.H., de Vos A.M.;
RT   "Crystal structures of the neurotrophin-binding domain of TrkA, TrkB
RT   and TrkC.";
RL   J. Mol. Biol. 290:149-159(1999).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-149; CYS-306; LEU-307; GLN-336;
RP   TYR-677; GLN-678; ARG-768 AND LYS-781.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [6]
RP   VARIANTS SER-664; TYR-677; CYS-736; PRO-745 AND PHE-766.
RX   PubMed=18293376; DOI=10.1002/humu.20707;
RA   Marchetti A., Felicioni L., Pelosi G., Del Grammastro M.,
RA   Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F.,
RA   Mucilli F., Camplese P., D'Antuono T., Sacco R., Buttitta F.;
RT   "Frequent mutations in the neurotrophic tyrosine receptor kinase gene
RT   family in large cell neuroendocrine carcinoma of the lung.";
RL   Hum. Mutat. 29:609-616(2008).
CC   -!- FUNCTION: Receptor for neurotrophin-3 (NT-3). This is a tyrosine-
CC       protein kinase receptor. Known substrates for the trk receptors
CC       are SHC1, PI-3 kinase, and PLCG1. The different isoforms do not
CC       have identical signaling properties.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Exists in a dynamic equilibrium between monomeric (low
CC       affinity) and dimeric (high affinity) structures. Binds SH2B2.
CC       Interacts with SQSTM1 and KIDINS220 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist;
CC       Name=A;
CC         IsoId=Q16288-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q16288-2; Sequence=VSP_002925, VSP_002926;
CC       Name=C;
CC         IsoId=Q16288-3; Sequence=VSP_002927;
CC       Name=D;
CC         IsoId=Q16288-4; Sequence=VSP_002924;
CC   -!- TISSUE SPECIFICITY: Widely expressed but mainly in nervous tissue.
CC       Isoform B is expressed at higher levels in adult brain than in
CC       fetal brain.
CC   -!- PTM: Ligand-mediated auto-phosphorylation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 2 LRR (leucine-rich) repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NTRK3ID433.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05012; AAA75374.1; -; mRNA.
DR   EMBL; S76475; AAB33111.1; -; mRNA.
DR   EMBL; S76476; AAB33112.1; -; mRNA.
DR   EMBL; AJ224521; CAA12029.1; -; Genomic_DNA.
DR   EMBL; AJ224522; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224523; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224524; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224525; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224526; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224527; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224528; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224529; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224530; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224531; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224532; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224533; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224534; CAA12029.1; JOINED; Genomic_DNA.
DR   EMBL; AJ224535; CAA12029.1; JOINED; Genomic_DNA.
DR   IPI; IPI00000824; -.
DR   IPI; IPI00185466; -.
DR   IPI; IPI00289961; -.
DR   IPI; IPI00376986; -.
DR   PIR; A55178; A55178.
DR   PIR; I73632; I73632.
DR   PIR; I73633; I73633.
DR   RefSeq; NP_001007157.1; -.
DR   RefSeq; NP_001012338.1; -.
DR   RefSeq; NP_002521.2; -.
DR   UniGene; Hs.410969; -.
DR   UniGene; Hs.706364; -.
DR   PDB; 1WWC; X-ray; 1.90 A; A=297-422.
DR   PDBsum; 1WWC; -.
DR   ProteinModelPortal; Q16288; -.
DR   SMR; Q16288; 32-190, 103-301, 212-391, 532-827.
DR   DIP; DIP-5723N; -.
DR   MINT; MINT-188514; -.
DR   STRING; Q16288; -.
DR   PhosphoSite; Q16288; -.
DR   Ensembl; ENST00000360948; ENSP00000354207; ENSG00000140538.
DR   GeneID; 4916; -.
DR   KEGG; hsa:4916; -.
DR   UCSC; uc002bme.1; human.
DR   UCSC; uc002bmf.1; human.
DR   UCSC; uc010bnh.1; human.
DR   CTD; 4916; -.
DR   GeneCards; GC15M088402; -.
DR   HGNC; HGNC:8033; NTRK3.
DR   HPA; CAB009233; -.
DR   MIM; 191316; gene.
DR   PharmGKB; PA31819; -.
DR   eggNOG; prNOG07449; -.
DR   HOGENOM; HBG402948; -.
DR   HOVERGEN; HBG056735; -.
DR   InParanoid; Q16288; -.
DR   OMA; ESTDNFV; -.
DR   OrthoDB; EOG9T4GDW; -.
DR   PhylomeDB; Q16288; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; trkrpathway; Neurotrophic factor-mediated Trk receptor signaling.
DR   NextBio; 18927; -.
DR   ArrayExpress; Q16288; -.
DR   Bgee; Q16288; -.
DR   CleanEx; HS_NTRK3; -.
DR   Genevestigator; Q16288; -.
DR   GermOnline; ENSG00000140538; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; IEA:EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000372; LRR-contain_N.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020446; Tyr_kin_neurotrophic_rcpt_3.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020777; Tyr_prot_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_prot_kinase_rcpt_2_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF284; Tyr_prot_kinase_NGF_rcpt; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF01462; LRRNT; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01942; NTKRECEPTOR3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00013; LRRNT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51450; LRR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Kinase;
KW   Leucine-rich repeat; Membrane; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Receptor; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     31
FT   CHAIN        32    839       NT-3 growth factor receptor.
FT                                /FTId=PRO_0000016731.
FT   TOPO_DOM     32    429       Extracellular (Potential).
FT   TRANSMEM    430    453       Helical; (Potential).
FT   TOPO_DOM    454    839       Cytoplasmic (Potential).
FT   REPEAT      102    125       LRR 1.
FT   REPEAT      126    149       LRR 2.
FT   DOMAIN      210    300       Ig-like C2-type 1.
FT   DOMAIN      309    382       Ig-like C2-type 2.
FT   DOMAIN      538    839       Protein kinase.
FT   NP_BIND     544    552       ATP (By similarity).
FT   ACT_SITE    679    679       Proton acceptor (By similarity).
FT   BINDING     572    572       ATP (By similarity).
FT   SITE        516    516       Interaction with SHC1 (By similarity).
FT   SITE        834    834       Interaction with PLC-gamma-1 (By
FT                                similarity).
FT   MOD_RES     516    516       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     705    705       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     709    709       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     710    710       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     834    834       Phosphotyrosine (By similarity).
FT   CARBOHYD     72     72       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     79     79       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    133    133       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    163    163       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    203    203       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    218    218       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    232    232       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    259    259       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    267    267       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    272    272       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    294    294       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    375    375       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    388    388       N-linked (GlcNAc...) (Potential).
FT   DISULFID    320    362
FT   VAR_SEQ     402    410       Missing (in isoform D).
FT                                /FTId=VSP_002924.
FT   VAR_SEQ     529    612       YVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLV
FT                                AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG
FT                                DP -> WVFSNIDNHGILNLKDNRDHLVPSTHYIYEEPEVQ
FT                                SGEVSYPRSHGFREIMLNPISLPGHSKPLNHGIYVEDVNVY
FT                                FSKGRHGF (in isoform B).
FT                                /FTId=VSP_002925.
FT   VAR_SEQ     613    839       Missing (in isoform B).
FT                                /FTId=VSP_002926.
FT   VAR_SEQ     712    725       Missing (in isoform C).
FT                                /FTId=VSP_002927.
FT   VARIANT     149    149       T -> R (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041471.
FT   VARIANT     306    306       R -> C (in dbSNP:rs56386352).
FT                                /FTId=VAR_041472.
FT   VARIANT     307    307       V -> L (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041473.
FT   VARIANT     336    336       L -> Q (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041474.
FT   VARIANT     664    664       A -> S (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046521.
FT   VARIANT     677    677       H -> Y (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041475.
FT   VARIANT     678    678       R -> Q (in dbSNP:rs55890138).
FT                                /FTId=VAR_041476.
FT   VARIANT     735    735       R -> F (in a lung large cell carcinoma
FT                                sample; somatic mutation; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_046770.
FT   VARIANT     736    736       W -> C (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046522.
FT   VARIANT     745    745       R -> P (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046523.
FT   VARIANT     766    766       Y -> F (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046524.
FT   VARIANT     768    768       K -> R (in dbSNP:rs55770052).
FT                                /FTId=VAR_046771.
FT   VARIANT     781    781       E -> K (in dbSNP:rs56393451).
FT                                /FTId=VAR_046772.
FT   CONFLICT     70     70       S -> N (in Ref. 2; AAB33111/AAB33112).
FT   CONFLICT    635    635       D -> N (in Ref. 1; AAA75374).
FT   STRAND      303    310
FT   STRAND      314    329
FT   STRAND      332    337
FT   STRAND      345    354
FT   STRAND      356    367
FT   HELIX       370    372
FT   STRAND      374    382
FT   STRAND      385    393
SQ   SEQUENCE   839 AA;  94428 MW;  7FE8846830083C08 CRC64;
     MDVSLCPAKC SFWRIFLLGS VWLDYVGSVL ACPANCVCSK TEINCRRPDD GNLFPLLEGQ
     DSGNSNGNAS INITDISRNI TSIHIENWRS LHTLNAVDME LYTGLQKLTI KNSGLRSIQP
     RAFAKNPHLR YINLSSNRLT TLSWQLFQTL SLRELQLEQN FFNCSCDIRW MQLWQEQGEA
     KLNSQNLYCI NADGSQLPLF RMNISQCDLP EISVSHVNLT VREGDNAVIT CNGSGSPLPD
     VDWIVTGLQS INTHQTNLNW TNVHAINLTL VNVTSEDNGF TLTCIAENVV GMSNASVALT
     VYYPPRVVSL EEPELRLEHC IEFVVRGNPP PTLHWLHNGQ PLRESKIIHV EYYQEGEISE
     GCLLFNKPTH YNNGNYTLIA KNPLGTANQT INGHFLKEPF PESTDNFILF DEVSPTPPIT
     VTHKPEEDTF GVSIAVGLAA FACVLLVVLF VMINKYGRRS KFGMKGPVAV ISGEEDSASP
     LHHINHGITT PSSLDAGPDT VVIGMTRIPV IENPQYFRQG HNCHKPDTYV QHIKRRDIVL
     KRELGEGAFG KVFLAECYNL SPTKDKMLVA VKALKDPTLA ARKDFQREAE LLTNLQHEHI
     VKFYGVCGDG DPLIMVFEYM KHGDLNKFLR AHGPDAMILV DGQPRQAKGE LGLSQMLHIA
     SQIASGMVYL ASQHFVHRDL ATRNCLVGAN LLVKIGDFGM SRDVYSTDYY RLFNPSGNDF
     CIWCEVGGHT MLPIRWMPPE SIMYRKFTTE SDVWSFGVIL WEIFTYGKQP WFQLSNTEVI
     ECITQGRVLE RPRVCPKEVY DVMLGCWQRE PQQRLNIKEI YKILHALGKA TPIYLDILG
//
